Treatment of Liver Cancer: Role of the Traditional Mongolian Medicine.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
11
2021
accepted:
19
01
2022
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
25
2
2022
Statut:
epublish
Résumé
Liver cancer is an extraordinarily heterogeneous malignancy with relatively high mortality and increasing incidence rate among the so far identified cancers. Improvements in liver cancer therapy have been made in the past decades, but therapeutics against liver cancer are still limited. Traditional Mongolian Medicine, formed and developed by the Mongolian people to maintain health in the medical practice of fighting against diseases, has been recognized as one of the key components of the world healthcare system. Traditional Mongolian Medicine has been used to treat various malignancies, including liver cancer, for a long time in Asia and its advantages have become more and more apparent. Herein, this review made a comprehensive summary of Traditional Mongolian Medicine, including the ideas in the liver cancer treatment, sources of medicines or prescriptions, traditional applications, modern pharmacological research, chemical structure and mechanisms of several monomer compounds isolated from Traditional Mongolian Medicine, with a view to finding promising drugs against liver cancer and expanding the clinical application of Traditional Mongolian Medicine in liver cancer therapy.
Identifiants
pubmed: 35198036
doi: 10.1155/2022/6535977
pmc: PMC8860509
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
6535977Informations de copyright
Copyright © 2022 Xiaomei Bao et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5232-8
pubmed: 22801644
Biomed Pharmacother. 2019 Jan;109:806-814
pubmed: 30551534
Zhonghua Yi Shi Za Zhi. 2010 Jan;40(1):29-32
pubmed: 20403260
Anticancer Agents Med Chem. 2017;17(7):941-947
pubmed: 28356025
J Ethnopharmacol. 2020 May 10;253:112685
pubmed: 32101774
Med Chem. 2011 Sep;7(5):432-42
pubmed: 21801152
Pharmacol Res. 2006 Sep;54(3):186-94
pubmed: 16765054
Zhong Yao Cai. 2003 Dec;26(12):875-7
pubmed: 15058208
Pathol Res Pract. 2017 May;213(5):531-540
pubmed: 28416328
Liver Cancer. 2020 Aug;9(4):382-396
pubmed: 32999866
Nat Rev Clin Oncol. 2015 Jul;12(7):408-24
pubmed: 26054909
Molecules. 2016 Dec 09;21(12):
pubmed: 27941678
Phytother Res. 2020 Dec;34(12):3226-3235
pubmed: 32618037
Asian Pac J Trop Biomed. 2013 Mar;3(3):244-52
pubmed: 23620847
Front Med. 2016 Jun;10(2):166-77
pubmed: 27193007
Hepatology. 2007 Dec;46(6):1779-90
pubmed: 17935225
Gastroenterology. 2019 Jan;156(2):510-524
pubmed: 30287171
Exp Ther Med. 2020 Apr;19(4):2989-2996
pubmed: 32256785
Zhongguo Zhong Yao Za Zhi. 2018 Aug;43(16):3412-3416
pubmed: 30200749
Hepatology. 2021 May;73(5):2039-2050
pubmed: 32986883
Zhongguo Zhong Yao Za Zhi. 2015 Sep;40(17):3379-84
pubmed: 26978976
J Ethnopharmacol. 2018 Mar 1;213:183-190
pubmed: 29166576
Zhongguo Zhong Yao Za Zhi. 2015 Mar;40(5):771-7
pubmed: 26087532
Nat Prod Res. 2021 Mar;35(5):815-818
pubmed: 30990333
Ann Transl Med. 2013 Jul;1(2):15
pubmed: 25332959
Cancers (Basel). 2020 Sep 24;12(10):
pubmed: 32987767